Unitil (NYSE:UTL) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.23 by 30.43 percent. This is a 66.67 percent increase over earnings of $0.18 per share from the same period last year.
Second Setback For Incyte’s LIMBER Program – Analyst Says ‘Resolution Timelines Unclear To Assess Impact’
The FDA issued a complete response letter (CRL) to Incyte Corporation (NASDAQ:INCY) ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD)…